A recent study [64] that prospectively followed 271 patients who were started on second-generation antidepressants (fluoxetine, paroxetine, citalopram, sertraline, escitalopram, venlafaxine, duloxetine, reboxetine, and mirtazapine) for new onset of RLS symptoms or exacerbation of existing symptoms during the course of ...